ICON7: A PHASE III RANDOMISED GYNAECOLOGIC CANCER INTERGROUP TRIAL OF CONCURRENT BEVACIZUMAB AND CHEMOTHERAPY FOLLOWED BY MAINTENANCE BEVACIZUMAB, VERSUS CHEMOTHERAPY ALONE IN WOMEN WITH NEWLY DIAGNOSED EPITHELIAL OVARIAN (EOC), PRIMARY PERITONEAL (PPC) OR FALLOPIAN TUBE CANCER (FTC)

Timothy Perren, AM Swart, Jacobus Pfisterer, JA Ledermann, Alain Lortholary, Gunnar B. Kristensen, Mark Carey, Philip Beale, Andrés Cervantes, Amit M. Oza

UCL Discovery (University College London) · 2010 · 38 citations · 0 references

Concepts